- Allergic Rhinitis and Sensitization
- Asthma and respiratory diseases
- Hearing Loss and Rehabilitation
- Ear Surgery and Otitis Media
- Dermatology and Skin Diseases
- Olfactory and Sensory Function Studies
- Dialysis and Renal Disease Management
- Hearing, Cochlea, Tinnitus, Genetics
- Medical Practices and Rehabilitation
Harvard University
2024
American Academy of Otolaryngology — Head and Neck Surgery
2024
Temple University
2024
Abstract Objective Age‐related hearing loss (ARHL) is a prevalent but often underdiagnosed and undertreated condition among individuals aged 50 above. It associated with various sociodemographic factors health risks including dementia, depression, cardiovascular disease, falls. While the causes of ARHL its downstream effects are well defined, there lack priority placed by clinicians as guidance regarding identification, education, management this condition. Purpose The purpose clinical...
Abstract Objective Allergen immunotherapy (AIT) is the therapeutic exposure to an allergen or allergens selected by clinical assessment and allergy testing decrease allergic symptoms induce immunologic tolerance. Inhalant AIT administered millions of patients for rhinitis (AR) asthma (AA) most commonly delivered as subcutaneous (SCIT) sublingual (SLIT). Despite its widespread use, there variability in initiation delivery safe effective immunotherapy, are opportunities evidence‐based...
Abstract Objective Age‐related hearing loss (ARHL) is a prevalent but often underdiagnosed and undertreated condition among individuals aged 50 above. It associated with various sociodemographic factors health risks including dementia, depression, cardiovascular disease, falls. While the causes of ARHL its downstream effects are well defined, there lack priority placed by clinicians as guidance regarding identification, education, management this condition. Purpose The purpose clinical...
Allergen immunotherapy (AIT) is the therapeutic exposure to an allergen or allergens selected by clinical assessment and allergy testing decrease allergic symptoms induce immunologic tolerance. Inhalant AIT administered millions of patients for rhinitis (AR) asthma (AA) most commonly delivered as subcutaneous (SCIT) sublingual (SLIT). Despite its widespread use, there variability in initiation delivery safe effective immunotherapy, are opportunities evidence-based recommendations improved...